{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJyD_MALDA","lastupdate":"2024-03-12T00:00:00.000Z","update_date":"2024-03-12T00:00:00.000Z","lastModified":"Dec 19, 2024","active":1,"confidence_score":90,"confidence_score_reason":"markets, not claimed","urlname":"vessi-medical","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$cqWsfv1bMWQKkJQsJtavecs6ZQjh4tPdoioVzUSWN9z0JZ5hEd2qSs","name":"Vessi Medical","oneliner":"Cryotherapy for treatment of urological tissue","registrar":"515272599","website":"https://www.vessimed.com","careerspage":"","founded_month":6,"founded_year":2015,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/18776827","instagram":""},"social":["https://www.linkedin.com/company/18776827"],"flattenedsociallinks":"https://www.linkedin.com/company/18776827","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"1-10","employees_exact":9,"patent":1,"raised":18200000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Vesi Medical"],"about":"Vessi Medical is developing a new approach in the treatment of urological tissue. The company treats superficial urological tissue using surface cryotherapy, utilizing extreme cold to freeze and destroy abnormal tissue. \n\nThe Vessi Medical system consists of a stand-alone console and a disposable catheter which is inserted into the bladder in a manner similar to existing intravesical techniques. Vessi's minimally invasive unique cryotherapy solution provides a therapeutic alternative to surgery while reducing the cost and complications associated with current treatments.\n\nFirst in human study (FIH) clinical trial was finalized (2023) , with very promising results.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"9116c9d3-9714-4cdd-a93c-a2a8eb015011","city":null,"type":null,"address":"Misgav, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":null,"news":[{"id":"qRS9WPYTvsUCZd5DDqrGeOwXPXtCH7nbv1XIsFbDH08Q4C1fI7gxXy","date":"Feb 14, 2024","link":"https://www.prnewswire.com/il/news-releases/vessi-medical-closes-16-5-million-series-a-round-for-innovative-cryotherapy-bladder-cancer-treatment-302061740.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Investment, Expansion","company":"Vessi Medical Ltd.","layoffs":"Not mentioned","summary":"Vessi Medical Ltd. has raised $16.5 million in a Series A financing round for its cryotherapy technology to treat Non Muscle Invasive Bladder Cancer. The round was led by an undisclosed global strategic investor, ALIVE- Israel HealthTech Fund, and Agriline, a trust of which UK investor Vincent Tchenguiz is a discretionary beneficiary. The funds will be used to expand Vessis R&D capabilities, conduct clinical studies in Israel and the U.S., and achieve regulatory clearance. The companys minimally invasive solution provides a new therapeutic alternative to the costly leading invasive surgical first-line therapy.","partners":"Not mentioned","customers":"Not mentioned","investors":["undisclosed global strategic investor","ALIVE- Israel HealthTech Fund","Agriline","The Trendlines Group"],"confidence":9,"key_topics":["Series A financing","Cryotherapy technology","Bladder Cancer","Clinical Studies","R&D Expansion"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$16.5 million","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2cg80KxoqNZr6ocDwt5vsQMoaeMZBis9EnQ9Su5fgh9tSJNwoUcsNr","news_summary":"Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b5c1cd30-c559-40fa-a775-55fd4ccfb200","date":"Sep 1, 2020","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3847517,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"medical device, funding","company":"Vessi Medical","layoffs":null,"summary":"Israel-based medical device startup Vessi Medical has secured $1.7 million in funding for its cryoablation solution for superficial bladder cancer. The company plans to conduct its first-in-human study in Q1 2021 to demonstrate the safety and efficacy of its Vessi intravesical cryotherapy device. Vessi Medical aims to replace existing surgical treatments with its bladder-specific cryotherapy technology, which can be used in outpatient clinic treatment. The funding round included participation from Agriline, The Trendlines Group, the Israel Innovation Authority, and ExitValley Investors. The companys progress in product development and ability to secure funding during the COVID-19 pandemic was praised. Vessi Medical was founded in 2015 and operates in northern Israel.","partners":null,"customers":null,"investors":"Agriline, The Trendlines Group, Israel Innovation Authority, ExitValley Investors","confidence":9,"key_topics":["cold therapy","bladder cancer","funding","product development","minimally invasive treatment"],"date_of_event":"2021-01-01","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$1.7 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YOgnenj7UA4qg0haTE6w8ghYMFwxxkRjOijJmAxr9ZTeyvMWcfd23l","news_summary":"Vessi Medical completes $1.7 million in funding for minimally invasive bladder cancer treatment","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"20d09d0d-da89-46a5-ac07-70b539275767","date":"May 28, 2019","link":"https://www.israel21c.org/freezing-out-tumors-may-offer-relief-in-bladder-cancer/","source":"www.israel21c.org","visible":1,"analysis":{"tags":["bladder cancer","cryoablation","treatment","medical device"],"company":"Vessi Medical","layoffs":null,"summary":"Vessi Medical, a startup incubated by the Trendlines Group, aims to reduce the rate of recurrence of non-muscle invasive bladder cancers (NMIBC) through cryoablation. Cryoablation uses extreme cold to destroy tissue and has been used for other types of cancer but never for NMIBC. Vessi Medicals cryotherapy is delivered as a spray to minimize physical contact with the bladder mucosa and reduce the risk of spreading cancer cells. The company is seeking $1-3 million in funding to begin clinical studies on humans and obtain FDA approval. NMIBC affects 2 million people globally, and Vessi Medicals initial market is estimated at $1.2 billion. If successful, commercialization could begin by the end of 2022.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["bladder cancer","cryoablation","treatment","medical device","clinical studies"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"iudS314ny25nMC5G0mSygZfPt9liOoNt6jvKTTeeTzn0KxKkSdZ4HR","news_summary":"Freezing out tumors may offer relief in bladder cancer","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4b5d7b4a-a542-4496-b0ff-1154e29c1fd1","date":"Mar 26, 2019","link":"https://biotuesdays.com/2019/03/26/2019-3-26-vessi-medical-developing-new-treatment-for-superficial-bladder-cancer/","source":"biotuesdays.com","visible":1,"analysis":{"tags":"medical technology","company":"Vessi Medical","layoffs":null,"summary":"Vessi Medical, a medical technology company, aims to revolutionize the treatment of superficial bladder cancer with its surface cryotherapy approach. The companys technology involves freezing the tumor to ablate it, eliminating the risk of dispersed cancer cells without damaging bladder functionality. Vessi is targeting a $1.2 billion market opportunity to treat non-muscle invasive bladder cancer. The company plans to conduct first-in-human trials in late 2019 or early 2020. Vessi is seeking up to $3 million in financing for its trials and regulatory submission process. The company plans to seek regulatory approvals and start commercialization in 2022. Vessis technology could also have applications in treating recurrent urinary tract infections, overactive bladder, and upper urinary tract carcinoma.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["bladder cancer","cryotherapy","treatment","market opportunity","clinical trials"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$3 million","structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"vyXoSSLeUvJOhGerBx0cZbOzYnWdwNytTQauID9U6gJ5Gmp7GZ2Rap","news_summary":"Vessi Medical developing new treatment for superficial bladder cancer - BioTuesdays","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5f743525-4c1c-4216-9d6a-9e9de801ce7f","date":"Feb 14, 2019","link":"https://www.timesofisrael.com/israeli-startup-seeks-to-freeze-bladder-tumors-after-seeing-success-in-pigs/","source":"www.timesofisrael.com","visible":1,"analysis":{"tags":"medical device","company":"Vessi Medical Ltd.","layoffs":null,"summary":"Israeli medical startup Vessi Medical Ltd. has developed a medical device for freezing tumors and treating superficial bladder cancers. The company has successfully concluded its first animal trials and is now seeking $1 million to $3 million in funding to begin human trials. Vessi Medicals bladder-specific cryotherapy technology aims to provide a less invasive alternative to current treatments for non-muscle invasive bladder cancer. The companys patent-pending cryotherapy system has a potential market target of $1.2 billion. The device can be inserted transurethrally into the bladder and uses a cryo-spray designed for the unique environment of the bladder. The funding for the research has been provided by The Trendlines Group, an Israeli incubator.","partners":null,"customers":null,"investors":"The Trendlines Group","confidence":8,"key_topics":["medical device","bladder cancer","cryotherapy","human trials","funding"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ZecBEWqblyWlhTneYWVQeMUPmJitQAVpgbaRNzAbWQVzgHxCNMqqjj","news_summary":"Israeli startup seeks to freeze bladder tumors after seeing success in pigs","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4a1344ff-776c-44ee-80b7-796cafe070e6","date":"Jan 22, 2019","link":"https://www.prnewswire.com/news-releases/vessi-medical-s-surface-cryoablation-therapy-for-bladder-cancer-demonstrates-successful-animal-trial-results-860025695.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical technology","company":"Vessi Medical Ltd.","layoffs":null,"summary":"Vessi Medical Ltd., a portfolio company of The Trendlines Group Ltd., announced a successful animal study demonstrating the use of its surface cryoablation therapy for the treatment of non-muscle invasive bladder cancer (NMIBC). The study showed localized, focused ablation on the target sites without damaging untargeted tissue. Vessis technology aims to provide a minimally invasive alternative to the current surgical procedure for NMIBC, which has a high recurrence rate and complications. The market for NMIBC treatment is estimated at $1.2 billion. Vessi plans to proceed to first-in-human trials after the successful animal study.","partners":null,"customers":null,"investors":"The Trendlines Group Ltd.","confidence":9,"key_topics":["bladder cancer","cryoablation therapy","minimally invasive","treatment","animal study"],"date_of_event":"January 22, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"JE93dLgAKpJVuZEaMYmmiFjOk28hLQq2mcVeoK7kWqCNA9kZhcpvM2","news_summary":"Vessi Medical's Surface Cryoablation Therapy for Bladder Cancer Demonstrates Successful Animal Trial Results","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":6,"techcommunityinvolvement":null,"mediagallery":[{"id":"ec53de18-cb1d-4b6a-9d8e-63c4827bc034","timestamp":"2018-11-25 13:12:21.000000","resources_type":2,"resources_title":"Vessy Medical","resources_file_name":"SmD3RVhsLA0","alt":"Vessy Medical logo","imageurl":"https://img.youtube.com/vi/SmD3RVhsLA0/0.jpg","url":"http://youtu.be/SmD3RVhsLA0"}],"tags":["catheters","targeted-therapy","urology","hospitals","oncology","cancer","medical-devices","doctors","treatments","medical-technologies","minimally-invasive"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":[],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":6,"lastfunding":"$16.5M","totalrounds":2,"fundingstage":"A","totalfunding":"$18.2M","publicinvestors":6,"lastpublicfunding":16500000,"totalpublicrounds":2,"totalpublicfunding":18200000},"team":[{"name":"Eyal Kochavi","email":"eyal@vessimed.com","phone":"0525235454","gender":"Male","userid":"5aWsRWhss5Rb5eSkM95zq2W6L3fepVhjSp6AaSwB6sXURqSOdlNBmD","bounced":false,"claimed":1,"founder":1,"urlname":"eyal-kochavi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgnMzn2AoM","position":"Founder & CEO","last_name":"Kochavi","claimtoken":"9X4MZf4WPdDcoRGYYfzsOaFc74GWa04Afqi1o2zXVaOi5p1z4NTygT","first_name":"Eyal","picturekey":null,"claimeddate":"2024-07-29","linkedinurl":"https://www.linkedin.com/in/eyal-kochavi-6680332/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-07-29 10:25:23.000000","initials":"EK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2019-12-22T00:00:00.000Z","crunchbaseid":"vessi-medical","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Vered Waxman","creator_email":"vered.waxman@sncentral.org","createdate":"2017-10-29T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"f7hAETbXDuqe69TS7Li3Bimq886vJYvaNQuo0WwNNpLNtCkdvMRwVn","date":"Feb 2024","amount":"$16.5M","source":"https://www.prnewswire.com/il/news-releases/vessi-medical-closes-16-5-million-series-a-round-for-innovative-cryotherapy-bladder-cancer-treatment-302061740.html","eventtype":"FundingRoundEvent","investment":[{"name":"ALIVE Israel Healthtech Fund","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/alive-israel-healthtech-fund","logokey":"$iyvXDXiUmrBAwISmgfr7RjMRRA3EorBHK6gh4HZD2oUu3lf6rmi9M3.png","tagline":null,"urlname":"/investor_page/alive-israel-healthtech-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KmU_cYIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Bz6QVSV7bAdTRt2ivbTwmvWn0n0UoThvWmjtuFz2N1dDQrQeTw3wQi","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$iyvXDXiUmrBAwISmgfr7RjMRRA3EorBHK6gh4HZD2oUu3lf6rmi9M3.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"Agriline","type":"Investor","amount":null,"hidden":false,"country":"United Kingdom","fullurl":"/investor_page/agriline-2","logokey":null,"tagline":null,"urlname":"/investor_page/agriline-2","isisraeli":0,"investorid":"WoF602DvMlVjoAb6ygmdmB7DE6wBtf5TtSA2RU07gC8VJEDrqhYiGa","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"QX0YvCXIFWBPuXRWzig0vDIATu56mPQSFGgeonLbf1Sz4agOhbLt16","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"The Trendlines Group","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/the-trendlines-group","logokey":"$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","tagline":null,"urlname":"/investor_page/the-trendlines-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7j4IwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"mdB1vVtrHGO5d0Z5bWSRDycqyyzYVgF8BbPtHMfz18AOyAE86RfUTe","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":16500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7r7vCww","date":"Mar 2020","amount":"$1.7M","source":"https://www.calcalist.co.il/articles/0,7340,L-3803493,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"The Trendlines Group","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/the-trendlines-group","logokey":"$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","tagline":null,"urlname":"/investor_page/the-trendlines-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7j4IwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"9b9a9171-239c-4372-98a2-7e71f1d7c155","fundingsubtype":"Incubator","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","leadcaption":"Lead ","followupcaption":""},{"name":"Agriline","type":"Company","amount":0,"hidden":true,"country":"United Kingdom","fullurl":"/company_page/agriline","logokey":null,"tagline":"Agriculture Products","urlname":"/company_page/agriline","isisraeli":null,"investorid":"lJM0XD921pHQTwqCbmFz24XJeyUOxBSQxpvEdAkLbJJszCVWBuYHXP","fundingtype":"Company","leadpartner":null,"investmentid":"16ade95d-85f9-44bc-bf58-48108d2c4917","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"5abbea94-11bb-4126-a6e6-1d6ed1407186","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""},{"name":"ExitValley","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/exitvalley","logokey":"$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","tagline":null,"urlname":"/investor_page/exitvalley","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ2Kp4EKDA","fundingtype":"Equity Crowdfunding","leadpartner":null,"investmentid":"cc2481aa-159a-45a3-91d0-c2162786a845","fundingsubtype":"Equity Crowdfunding","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"6/2015","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Vessi Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$cqWsfv1bMWQKkJQsJtavecs6ZQjh4tPdoioVzUSWN9z0JZ5hEd2qSs","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$cqWsfv1bMWQKkJQsJtavecs6ZQjh4tPdoioVzUSWN9z0JZ5hEd2qSs","seoabout":"Vessi Medical is developing a new approach in the treatment of urological tissue. The company treats superficial urological tissue using surface cryotherap...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":1,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":[],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"f7hAETbXDuqe69TS7Li3Bimq886vJYvaNQuo0WwNNpLNtCkdvMRwVn","date":"Feb 2024","amount":"$16.5M","source":"https://www.prnewswire.com/il/news-releases/vessi-medical-closes-16-5-million-series-a-round-for-innovative-cryotherapy-bladder-cancer-treatment-302061740.html","eventtype":"FundingRoundEvent","investment":[{"name":"ALIVE Israel Healthtech Fund","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/alive-israel-healthtech-fund","logokey":"$iyvXDXiUmrBAwISmgfr7RjMRRA3EorBHK6gh4HZD2oUu3lf6rmi9M3.png","tagline":null,"urlname":"/investor_page/alive-israel-healthtech-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KmU_cYIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Bz6QVSV7bAdTRt2ivbTwmvWn0n0UoThvWmjtuFz2N1dDQrQeTw3wQi","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$iyvXDXiUmrBAwISmgfr7RjMRRA3EorBHK6gh4HZD2oUu3lf6rmi9M3.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"Agriline","type":"Investor","amount":null,"hidden":false,"country":"United Kingdom","fullurl":"/investor_page/agriline-2","logokey":null,"tagline":null,"urlname":"/investor_page/agriline-2","isisraeli":0,"investorid":"WoF602DvMlVjoAb6ygmdmB7DE6wBtf5TtSA2RU07gC8VJEDrqhYiGa","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"QX0YvCXIFWBPuXRWzig0vDIATu56mPQSFGgeonLbf1Sz4agOhbLt16","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"The Trendlines Group","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/the-trendlines-group","logokey":"$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","tagline":null,"urlname":"/investor_page/the-trendlines-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7j4IwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"mdB1vVtrHGO5d0Z5bWSRDycqyyzYVgF8BbPtHMfz18AOyAE86RfUTe","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":16500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7r7vCww","date":"Mar 2020","amount":"$1.7M","source":"https://www.calcalist.co.il/articles/0,7340,L-3803493,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"The Trendlines Group","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/the-trendlines-group","logokey":"$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","tagline":null,"urlname":"/investor_page/the-trendlines-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7j4IwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"9b9a9171-239c-4372-98a2-7e71f1d7c155","fundingsubtype":"Incubator","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zXClA4XyhSlBGE6oIvcxk4zLnunQcv7vkMmdBn2d3fReDKuNYbEeCt.jpeg","leadcaption":"Lead ","followupcaption":""},{"name":"Agriline","type":"Company","amount":0,"hidden":true,"country":"United Kingdom","fullurl":"/company_page/agriline","logokey":null,"tagline":"Agriculture Products","urlname":"/company_page/agriline","isisraeli":null,"investorid":"lJM0XD921pHQTwqCbmFz24XJeyUOxBSQxpvEdAkLbJJszCVWBuYHXP","fundingtype":"Company","leadpartner":null,"investmentid":"16ade95d-85f9-44bc-bf58-48108d2c4917","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"5abbea94-11bb-4126-a6e6-1d6ed1407186","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""},{"name":"ExitValley","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/exitvalley","logokey":"$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","tagline":null,"urlname":"/investor_page/exitvalley","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ2Kp4EKDA","fundingtype":"Equity Crowdfunding","leadpartner":null,"investmentid":"cc2481aa-159a-45a3-91d0-c2162786a845","fundingsubtype":"Equity Crowdfunding","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}